Data / Form D filings / Zonaliz, Inc.
Zonaliz, Inc.: Form D filing
Zonaliz, Inc., a biotechnology company in Palo Alto, CA, filed a Form D with the SEC in 2026. The latest, on October 5, 2026, reports $2.5 million sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1380 OAK CREEK DRIVE, Palo Alto, CA, 94304
- Phone
- (650) 531-9140
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157556
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5 | New notice | Indefinite | $2,500,000 | 2 | Sep 21 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gaoxian Chen | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
Every Form D from the week of Oct 5 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Zonaliz, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.